Nutrastar International (NUIN) Gross Profit Margin starting from the third quarter 2015 to third quarter 2014, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Nutrastar International Inc.  (NUIN)


Nutrastar International's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUIN Gross Profit Margin (Sep 30 2015)
Q3 		(Jun 30 2015)
Q2 		(Mar 31 2015)
Q1 		(Dec 31 2014)
Q4 		(Sep 30 2014)
Q3
Y / Y Revenue Change -1.31 %
Seq. Revenue Change -16.8 %
Revenue In Millions $11.02
Gross Profit Margin 80.53 %
Gross Profit Margin Total Ranking # 580
Gross Profit In Millions $8.87
Y / Y Gross Profit Change -1.32 %
Seq. Gross Profit Change -14.04 %


Commenting Third Quarter 2015 Gross Profit Margin
Nutrastar International Inc. increased Gross Profit Margin through reduction in Cost of Sales and despite contraction in Gross Profit by -14.04 % and Revenue by -16.8 %. Gross Profit Margin in Q3 was 80.53 %, above company average.


Observing third quarter 2015 results within Biotechnology & Pharmaceuticals industry 11 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 580, from total ranking in the previous quarter at 731.
Learn about Gross Margin
NUIN's Gross Profit Margin third quarter 2015 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 12
Healthcare Sector # 71
Overall # 474

Gross Profit Margin Statistics
High Average Low
80.54 % 77.67 % 74.08 %
(Sep 30 2014)   (Mar 31 2012)


NUIN Gross Income Trends • More of NUIN's Profitabilty Ratios • NUIN Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
NUIN's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NUIN's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NUIN's Competitors
Gross Profit Margin Profit Margin for Nutrastar International's Suppliers
Gross Profit Margin Profit Margin for NUIN's Customers

You may also want to know
NUIN's Annual Growth Rates NUIN's Profitability Ratios NUIN's Asset Turnover Ratio NUIN's Dividend Growth
NUIN's Roe NUIN's Valuation Ratios NUIN's Financial Strength Ratios NUIN's Gross Profit Growth
NUIN's Roa NUIN's Inventory Turnover Ratio NUIN's Growth Rates NUIN's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2015, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginSep 30 2015 MRQ Gross ProfitSep 30 2015 MRQ Revenue
Pluri Inc   96.84 %$ 0.092  Millions$ 0.095  Millions
Agentix Corp   92.13 %$ 0.016  Millions$ 0.017  Millions
Seagen Inc   92.12 %$ 77.447  Millions$ 84.072  Millions
Biogen Inc   88.84 %$ 2,467.831  Millions$ 2,777.859  Millions
Biocryst Pharmaceuticals Inc   87.75 %$ 9.641  Millions$ 10.987  Millions
Gilead Sciences Inc   87.17 %$ 7,231.000  Millions$ 8,295.000  Millions
Exelixis Inc   85.59 %$ 8.434  Millions$ 9.854  Millions
Cyclo Therapeutics Inc   85.10 %$ 0.200  Millions$ 0.235  Millions
Acorda Therapeutics Inc   83.31 %$ 123.458  Millions$ 148.199  Millions
Amgen Inc   81.93 %$ 4,689.000  Millions$ 5,723.000  Millions
Lineage Cell Therapeutics Inc   81.27 %$ 1.874  Millions$ 2.306  Millions
Nutrastar International Inc.  80.53 %$ 8.873  Millions$ 11.018  Millions
Zeo Scientifix Inc   80.41 %$ 0.050  Millions$ 0.062  Millions
Regenxbio Inc   77.46 %$ 0.883  Millions$ 1.140  Millions
Fresh Tracks Therapeutics Inc   73.97 %$ 3.711  Millions$ 5.017  Millions
Bio techne Corp  67.09 %$ 75.391  Millions$ 112.381  Millions
Xtant Medical Holdings Inc   65.89 %$ 11.657  Millions$ 17.693  Millions
China Biologic Products Holdings Inc   64.51 %$ 50.806  Millions$ 78.751  Millions
Ds Healthcare Group, Inc.  64.39 %$ 2.009  Millions$ 3.120  Millions
Nanostring Technologies Inc   59.92 %$ 9.404  Millions$ 15.693  Millions
Protalix Biotherapeutics inc   59.87 %$ 3.500  Millions$ 5.846  Millions
Enzo Biochem Inc  58.96 %$ 14.845  Millions$ 25.177  Millions
Novavax inc   57.90 %$ 3.778  Millions$ 6.525  Millions
Repligen Corp  57.38 %$ 11.370  Millions$ 19.814  Millions
United Bancshares Inc  46.15 %$ 0.401  Millions$ 0.870  Millions
Halozyme Therapeutics Inc   45.84 %$ 14.600  Millions$ 31.853  Millions
Sorrento Therapeutics Inc   45.24 %$ 0.499  Millions$ 1.103  Millions
Vericel Corporation  40.12 %$ 4.537  Millions$ 11.309  Millions
Adma Biologics Inc   39.93 %$ 0.740  Millions$ 1.852  Millions
Cellular Biomedicine Group Inc   29.04 %$ 0.181  Millions$ 0.625  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.